Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly targeting protein kinases involved in inflammatory and oncological pathways. Shows potential in the development of diagnostic agents and radiolabeled tracers for positron emission tomography (PET) due to the presence of iodine, enabling non-invasive imaging of receptor expression in tumors. Also explored for its role in central nervous system drug candidates, where the piperidine and pyrazolopyrimidine moieties contribute to blood-brain barrier penetration and receptor binding affinity.